Idan Farber

Dr. Idan Farber

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
IFIdan Farber
Idan Farber
MWMuhammad Wated
Muhammad Wated
RSRonen Schuster
Ronen Schuster
LSLihie Sheffer
Lihie Sheffer
YAYuval Anav
Yuval Anav
ETErez Tsumi
Erez Tsumi
Purpose: Regulation of inflammation and re-epithelialization are critical for efficient wound healing. This study explores the role of human α1-antitrypsin (hAAT), an immunomodulatory protein, in modulating inflammation and promoting re-epithelialization across various epithelial cell types.Methods: In-vitro, epithelial gap closure and migration assays were performed using two human epithelial cell lines—HaCaT and A549 cells with and without mitomycin C treatment. These cell lines were also used in an in-vitro gel-directed epithelial migration assay. Cells were treated with hAAT, and the gap area was measured using image analysis. Gene expression of inflammatory markers (IL-1β, IL-6, and TNFα) and adhesion molecules (desmoglein-1, plectin, and integrin α6β4) were analyzed using qPCR. In-vivo, corneal abrasions were induced in C57BL/6 mice using an Ophthalmic Burr. Mice received topical hAAT treatment immediately after injury and every 6 hours thereafter. Wound closure was assessed by applying the standard ophthalmic staining technique, fluorescein, and image analysis. Inflammatory markers and adhesion molecule expression were evaluated using qPCR and immunohistochemistry.Results: In-vitro, hAAT accelerated epithelial gap closure and increased migration distance, independent of cell proliferation. hAAT-treated cells also exhibited earlier peak expressions of IL-1β and IL-6. In-vivo, hAAT treatment accelerated corneal wound closure and resulted in a preference for IL-1Ra over IL-1β expression. hAAT also enhanced the expression of desmoglein-1, plectin, and integrin α6β4, both in-vitro and in-vivo, and increased desmoglein-1 expression in the epithelial migration zone of mouse cornea.Conclusions: hAAT enhances re-epithelialization by modulating inflammation, promoting epithelial cell migration, and regulating expression of adhesion molecules.

19 November 2025 in Scientific Reports
Verified
Journal Article
Open access
IFIdan Farber
Idan Farber
LSLihie Sheffer
Lihie Sheffer
YAYuval Anav
Yuval Anav
OGOron Goldstein
Oron Goldstein
DHDor Halpern
Dor Halpern
ESEldad Silberstein
Eldad Silberstein
Wound healing requires a delicate balance between cellular and molecular factors, all affected by reactive oxygen species (ROS). While ROS decontaminate, they also might lead to impaired wound healing, as evident in radiation-exposed skin and in venous insufficiency. Human alpha-1 antitrypsin (hAAT) is a circulating antiprotease that is anti-inflammatory and tissue-protective. Accordingly, tissue repair is enhanced in hAAT-rich conditions. hAAT undergoes oxidative modification in high-ROS environments, which alters its functional properties. While its antiprotease function is lost, the consequences of oxidation on its anti-inflammatory and tissue-protective properties are still under investigation. To explore this, excisional skin wound closure rates were first examined on irradiated skin and then tested using an iron-loading venous insufficiency model. The former was tested on hAAT transgenic mice, the latter on wild-type mice using topical clinical-grade hAAT. In-vitro, hAAT was oxidized using H2O2 (0.5, 5 and 25 mM), then tested for elastase inhibition and added to an in-vitro A549 epithelial cell gap closure assay and a RAW 264.7 macrophage cell response assay. ROS levels, inflammatory responses and NRF2/ARE activation were determined. Results demonstrated wound closure was impaired in wild-type mice by both radiation and iron. In contrast, hAAT-transgenic mice exhibited accelerated wound closure in both normal and irradiated skin, and topical hAAT improved wound healing in the venous insufficiency model. hAATOX lacked elastase inhibition across the three oxidation levels, yet highly oxidized hAAT (hAATOX 25mM) impaired epithelial gap closure and weakly oxidized hAAT (hAATOX 0.5mM) enhanced gap closure. All forms of hAATOX elevated ROS in macrophages, as well as the expression of iNOS and catalase, IL-1β, TNFα and CXCL-1. Unexpectedly, the NRF2/ARE pathway was activated by hAATOX 25mM and suppressed by hAATOX 0.5mM, and hAATOX 0.5 mM induced IL-1 receptor antagonist expression. In conclusion, oxidation levels of hAAT modify its effects on inflammation and tissue repair. While protease inhibition is lost, anti-inflammatory and repair attributes are maintained under low oxidative conditions, suggesting a molecular profile that is physiologically attuned to local signals. Considering its safety record, the study proposes that hAAT therapy is poised for trials in the context of defective tissue repair under oxidative conditions.

27 April 2026 in Advances in Wound Care
Verified
Journal Article
Closed access
DHDor Halpern
Dor Halpern
IFIdan Farber
Idan Farber
YAYuval Anav
Yuval Anav
ATAleksandra A Tsitrina
Aleksandra A Tsitrina
ELEli C. Lewis
Eli C. Lewis
ESEldad Silberstein
Eldad Silberstein
Objective: Fat grafting is widely applied for various purposes, including volume restoration, improving tissue quality, and promoting wound healing, but it has poor long-term graft survival predictability. Alpha-1-antitrypsin (AAT) administration is hypothesized to improve fat graft outcomes by expediting inflammatory resolution and graft vascularity and reducing necrosis. Approach: Mice heterozygote to human AAT was grafted fat under the scalp alongside 400 µg/graft AAT or albumin (ALB) on days 0 and 3. Graft volume was determined by micro-magnetic resonance imaging, and explants were assessed for viability, histology, immunohistochemistry, and expression of selected genes. AAT expression was examined in hypoxia-exposed adipose-derived stem cells (ADSCs). Results: After 90 days, AAT-treated grafts maintained higher volumes (70.06% vs. 34.54%, n = 8, p = 0.02) and displayed improved tissue quality. On day 10 after grafting, grafts exhibited more blood vessels (mean 1.94/mm 2 vs. 0.33/mm 2 ) and 6.25-fold more adiponectin transcript levels ( n = 12, p = 0.02). Although day-3 interleukin (IL)-1β expression was 5-fold greater in AAT-treated grafts ( n = 6, p = 0.4), day-10 IL-1β expression was 2-fold lower compared to ALB-treated grafts ( n = 22, p = 0.01). In the Methoxynitrosulfophenyl-tetrazolium carboxanilide (XTT) assay, day-3 AAT-treated grafts were 1.56-fold more metabolically functional ( n = 6, p = 0.04) and exhibited greater perilipin-positive regions (18.5% versus 3.1%). Hypoxia-exposed ADSC expressed 9-fold higher AAT transcript levels ( p = 0.04). Innovation: Fat grafting outcomes improved by early AAT treatment, probably by accelerating inflammatory resolution. Due to its marked safety profile, the study’s findings are for adjunct clinical-grade AAT therapy. Conclusion: AAT has a promising potential to be utilized as a fat graft outcome enhancer in terms of volume retention predictability and tissue quality. Dor Halpern

1 October 2025 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
IFIdan Farber
Idan Farber
AIAhed Imtirat
Ahed Imtirat
MRMor Erick Rosenblum
Mor Erick Rosenblum
TYTal Yahalomi
Tal Yahalomi
AAAsaf Achiron
Asaf Achiron
ETErez Tsumi
Erez Tsumi
Background/Aims: Pediatric cataracts are considered a leading cause of visual impairment. While intraocular lens (IOL) implantation is mostly performed for children > 2 years, its use in younger children remains contentious. This study assessed primary IOL in a unique pediatric population characterized by limited adherence to postoperative care, where primary IOL implantation was favored to minimize the risk of prolonged uncorrected aphakia. Methods: This retrospective study examined primary IOL implantation outcomes in children across three age brackets: below 6 months, 6– 12 months, and 1– 18 years, focusing on best-corrected visual acuity (BCVA) and complications including glaucoma, toxic anterior segment syndrome (TASS), retinal detachment (RD), and yttrium-aluminum-garnet (YAG)/membranectomy. Results: 169 eyes from 119 patients were evaluated over a median follow-up period of 6.4 years. No significant differences were observed between age groups in terms of LogMAR visual acuity (p = 0.344) or the incidence of postoperative complications such as glaucoma (p = 0.244), retinal detachment (p = 0.244), or TASS (p = 0.960). The incidence of YAG capsulotomy/membranectomy was highest in the < 6 months group (36%), compared to 22% in the 6– 12 months group and 13% in the > 1 year group (p = 0.020). Among unilateral cases, all 3 patients diagnosed before 6 months required YAG/membranectomy. Conclusion: Primary IOL implantation for pediatric cataracts resulted in comparable visual acuity and overall complication rates across all age groups. Although a higher incidence of YAG/membranectomy was observed in children under 6 months, particularly among unilateral cases, most patients still avoided the need for additional surgical intervention. These findings support primary IOL implantation as a valid option for selected patients.

19 April 2024 in Asian Journal of Andrology
Verified
Journal Article
Open access
NNNitza Heiman Newman
Nitza Heiman Newman
IFIdan Farber
Idan Farber
ELEitan Lunenfeld
Eitan Lunenfeld
AZAtif Zeadna
Atif Zeadna
IVIris Har Vardi
Iris Har Vardi
ZAZaki Assi
Zaki Assi
Infertility, affecting one in six couples, is often related to the male partner’s congenital and/or environmental conditions or complications postsurgery. This retrospective study examines the link between orchiopexy for undescended testicles (UDT) and testicular torsion (TT) in childhood and adult fertility as assessed through sperm analysis. The study involved the analysis of semen samples from 7743 patients collected at Soroka University Medical Center (Beer Sheva, Israel) between January 2009 and December 2017. Patients were classified into two groups based on sperm concentration: those with concentrations below 5 × 106sperm per ml (AS group) and those above (MN group). Medical records and surgical histories were reviewed, categorizing orchiopexies by surgical approach. Among 140 individuals who had undergone pediatric surgery, 83 (59.3%) were placed in the MN group and 57 (40.7%) in the AS group. A higher likelihood of being in the MN group was observed in Jewish compared to Arab patients (75.9% vs 24.1%,P= 0.006). In cases of childhood UDT, 45 (78.9%) patients exhibited sperm concentrations below 5 × 106sperm per ml (P< 0.001), and 66 (76.7%) had undergone unilateral and 18 (20.9%) bilateral orchiopexy. Bilateral orchiopexy was significantly associated with lower sperm concentration, total motility, and progressive motility than unilateral cases (P= 0.014,P= 0.001, andP= 0.031, respectively). Multivariate analysis identified UDT as a weak risk factor for low sperm concentration (odds ratio [OR]: 2.712,P= 0.078), with bilateral UDT further increasing this risk (OR: 6.314,P= 0.012). Jewish ethnicity and TT diagnosis were associated with a reduced risk of sperm concentrations below 5 × 106sperm per ml. The findings indicate that initial diagnosis, surgical approach, and ethnicity markedly influence male fertility outcomes following pediatric orchiopexy.

27 October 2026 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
IFIdan Farber
Idan Farber
YAYuval Anav
Yuval Anav
DHDor Halpern
Dor Halpern
LSLihie Sheffer
Lihie Sheffer
OGOron Goldstein
Oron Goldstein
ESEldad Silberstein
Eldad Silberstein
Introduction: Capsular contracture remains a significant complication after alloplastic breast reconstruction, particularly following post-mastectomy radiotherapy. This study evaluated the therapeutic potential of human alpha-1 antitrypsin (hAAT) in reducing radiation-associated capsular fibrosis. Methods: Textured silicone-discs were implanted subcutaneously in female C57BL/6 mice on day 0, followed immediately by localized 15 Gy irradiation of the implantation site. Mice were assigned to non-irradiated controls, irradiated albumin-treated controls, or irradiated hAAT-treated groups. Albumin control or hAAT was administered locally on days 0, 3, and 6. Capsule formation was assessed by MRI on day 21. Explants were collected on days 14 and 21 for histology, and day-21 tissues were further analyzed by gene expression profiling of inflammatory and fibrotic mediators. Human dermal fibroblasts were used to assess hAAT effects on radiation-associated TGFβ expression in vitro. Result: Irradiated controls developed significant capsule thickening, disorganized collagen deposition, and inflammatory infiltration compared with non-irradiated controls. In contrast, hAAT-treated irradiated mice demonstrated capsule thickness comparable to non-irradiated controls, with improved extracellular matrix organization and reduced inflammation. hAAT treatment reduced interleukin-1 beta (IL-1β), transforming growth factor beta (TGFβ), and collagen type I expression, increased the interleukin-1 receptor antagonist/interleukin-1 beta (IL-1Ra/IL-1β) ratio, and upregulated Sloan-Kettering Institute proto-oncogene (SKI) expression, resulting in predominance of SKI over TGFβ compared with irradiated controls. In a separate in-vitro human dermal fibroblast model, hAAT attenuated radiation-induced TGFβ upregulation. Conclusion: Local hAAT treatment may reduce early radiation-associated peri-silicone inflammation and fibrotic capsule formation, supporting its further investigation as a prophylactic strategy in implant-based reconstruction.